Triamcinolone Diacetate
Triamcinolone Diacetate Brand names, Triamcinolone Diacetate Analogs
- Adcortyl
- Aristocort
- Aristocort A
- Aristocort Tablets
- Aristogel
- Aristospan
- Azmacort
- Celeste
- Cinolone
- Cinolone-T
- Delphicort
- Fluoxiprednisolone
- Fluoxyprednisolone
- Flutex
- Kenacort
- Kenacort-A
- Kenacort-Ag
- Kenalog
- Kenalog in Orabase
- Kenalog-10
- Kenalog-40
- Kenalog-H
- Ledercort
- Nasacort
- Nasacort Aq
- Nasacort Hfa
- Omcilon
- Omicilon
- Oracort
- Oralone
- Orion
- Polcortolon
- Rodinolone
- Sk-Triamcinolone
- Tiamcinolonum [Inn-Latin]
- Tri-Nasal
- Triacet
- Triacort
- Triam-Tablinen
- Triamcet
- Triamcinalone
- Triamcinlon
- Triamcinolon
- Triamcinolona [Inn-Spanish]
- Triamcinolone Acetonide
- Triamcinolone Acetonide in Absorbase
- Triamcinolone Diacetate
- Triamcinolone [Usan:Ban:Inn:Jan]
- Triamcinolonum [Inn]
- Triatex
- Tricortale
- Triderm
- Trymex
- Vetalog
- Volon
Triamcinolone Diacetate Brand Names Mixture
- Aristoform R Crm 0.1% (Clioquinol + Triamcinolone Acetonide)
- Derma-4 Ont (Neomycin Sulfate + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
- Kenacomb Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
- Kenacomb Mild Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
- Kenacomb Mild Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
- Kenacomb Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
- Kenacomb Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Mecomb Crm 0.1% (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Oribiotic Ointment (Bacitracin + Lidocaine + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Panolog Cream (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
- Panolog Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
- Ratio-Triacomb Regular Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Solvaderm Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
- Theraderm Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Viaderm Kc Crm (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Viaderm Kc Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
Triamcinolone Diacetate Chemical_Formula
Triamcinolone Diacetate RX_link
Triamcinolone Diacetate fda sheet
Triamcinolone Diacetate msds (material safety sheet)
Triamcinolone Diacetate Synthesis Reference
Triamcinolone Diacetate Molecular Weight
Triamcinolone Diacetate Melting Point
Triamcinolone Diacetate H2O Solubility
Triamcinolone Diacetate State
Triamcinolone Diacetate LogP
Triamcinolone Diacetate Dosage Forms
Triamcinolone Diacetate Indication
Triamcinolone Diacetate Pharmacology
Triamcinolone Diacetate Absorption
Triamcinolone Diacetate side effects and Toxicity
Triamcinolone Diacetate Patient Information
Patients being treated with Azmacort Inhalation Aerosol should receive the following information and instructions. This information is intended to aid them in the safe and effective use of this medication. It is not a complete disclosure of all possible adverse or intended effects.
Patients should use Azmacort Inhalation Aerosol at regular intervals as directed. Results of clinical trials indicate that significant improvement in asthma may occur by 1 week, but maximum benefit may not be achieved for 2 weeks or more. The patient should not increase the prescribed dosage but should contact the physician if symptoms do not improve or if the condition worsens.
In clinical studies and post-marketing experience with Azmacort Inhalation Aerosol, local infections of the oropharynx with Candida albicans have occurred. When such an infection develops, it should be treated with appropriate local or systemic (i.e., oral antifungal) therapy while remaining on treatment with Azmacort Inhalation Aerosol. However, at times therapy with Azmacort Inhalation Aerosol may need to be interrupted.
Patients should be instructed to track their use of Azmacort Inhalation Aerosol and to dispose of the canister after 240 actuations since reliable dose delivery cannot be assured after 240 doses.
Patients who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chickenpox or measles and if exposed, to obtain medical advice.
